Skip to main content
Top
Published in: Clinical Rheumatology 10/2018

01-10-2018 | Original Article

Negative temporal artery biopsy: predictive factors for giant cell arteritis diagnosis and alternate diagnoses of patients without arteritis

Authors: Gil Bornstein, Iris Barshack, Nira Koren-Morag, Ilan Ben-Zvi, Nadav Furie, Chagai Grossman

Published in: Clinical Rheumatology | Issue 10/2018

Login to get access

Abstract

To investigate whether among patients with a negative temporal artery biopsy (TAB) there are clinical features that may differentiate between patients with an eventual diagnosis of giant cell arteritis (GCA) and those without arteritis, and to assess the eventual diagnoses of patients without arteritis. Retrospective analysis of patients with a negative TAB performed between 1/1/2000 and 31/12/2015. Information collected included baseline clinical and laboratory data. Patients’ final diagnoses were obtained from medical records. Patients eventually diagnosed with GCA were compared with those without arteritis, and predictive features for GCA diagnosis were assessed. A total of 154 patients with a negative TAB were included in the study. Among them, 31 (20%) were eventually diagnosed with GCA. The leading alternative diagnoses of patients without arteritis were self-limited disease (23%), isolated polymyalgia rheumatica (PMR) (18%), and neurological conditions (17%). In the multivariate analysis, predictors for diagnosis of GCA among patients with a negative TAB included PMR (OR = 2.86, 95% CI 1.06–7.69), platelet count (OR = 1.28, 95% CI 1.07–1.53), and ACR score > 2 (OR = 13.4, 95% CI 4.27–42.03). Among patients with a negative TAB, the best predictors for diagnosis of GCA are fulfillment of the ACR criteria, a clinical diagnosis of PMR, and high platelet levels. These features may aid in the diagnostic work-up of patients with a negative TAB.
Literature
1.
go back to reference Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J, Llorca J (2009) Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 61:1454–1461CrossRefPubMed Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J, Llorca J (2009) Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 61:1454–1461CrossRefPubMed
2.
go back to reference Nesher G (2014) The diagnosis and classification of giant cell arteritis. J Autoimmun 48–49:73–75CrossRefPubMed Nesher G (2014) The diagnosis and classification of giant cell arteritis. J Autoimmun 48–49:73–75CrossRefPubMed
3.
go back to reference Muratore F, Pazzola G, Pipitone N, Boiardi L, Salvarani C (2014) Large-vessel involvement in giant cell arteritis and polymyalgia rheumatica. Clin Exp Rheumatol 32(3 Suppl 82):S106–S111PubMed Muratore F, Pazzola G, Pipitone N, Boiardi L, Salvarani C (2014) Large-vessel involvement in giant cell arteritis and polymyalgia rheumatica. Clin Exp Rheumatol 32(3 Suppl 82):S106–S111PubMed
4.
go back to reference Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J (2005) Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine 84:269–276CrossRefPubMed Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J (2005) Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine 84:269–276CrossRefPubMed
5.
go back to reference Jennette JC, Falk RJ (2007) The role of pathology in the diagnosis of systemic vasculitis. Clin Exp Rheumatol 25(1 Suppl 44):S52–S56PubMed Jennette JC, Falk RJ (2007) The role of pathology in the diagnosis of systemic vasculitis. Clin Exp Rheumatol 25(1 Suppl 44):S52–S56PubMed
6.
go back to reference Gonzalez-Gay MA (2005) The diagnosis and management of patients with giant cell arteritis. J Rheumatol 32:1186–1188PubMed Gonzalez-Gay MA (2005) The diagnosis and management of patients with giant cell arteritis. J Rheumatol 32:1186–1188PubMed
7.
go back to reference Salvarani C, Macchioni P, Zizzi F, Mantovani W, Rossi F, Castri C et al (1991) Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum 34:351–356CrossRefPubMed Salvarani C, Macchioni P, Zizzi F, Mantovani W, Rossi F, Castri C et al (1991) Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum 34:351–356CrossRefPubMed
8.
go back to reference Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Gonzalez-Louzao C, Rodriguez-Ledo P (2001) Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum 30:249–256CrossRefPubMed Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Gonzalez-Louzao C, Rodriguez-Ledo P (2001) Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum 30:249–256CrossRefPubMed
9.
go back to reference Duhaut P, Pinede L, Bornet H, Demolombe-Rague S, Dumontet C, Ninet J, Loire R, Pasquier J (1999) Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease. Groupe de Recherche sur l’Arterite a Cellules Geantes. Ann Rheum Dis 58:335–341CrossRefPubMedPubMedCentral Duhaut P, Pinede L, Bornet H, Demolombe-Rague S, Dumontet C, Ninet J, Loire R, Pasquier J (1999) Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease. Groupe de Recherche sur l’Arterite a Cellules Geantes. Ann Rheum Dis 58:335–341CrossRefPubMedPubMedCentral
10.
go back to reference Grossman C, Barshack I, Bornstein G, Ben-Zvi I (2015) Is temporal artery biopsy essential in all cases of suspected giant cell arteritis? Clin Exp Rheumatol 33(2 Suppl 89):S-84–S-89 Grossman C, Barshack I, Bornstein G, Ben-Zvi I (2015) Is temporal artery biopsy essential in all cases of suspected giant cell arteritis? Clin Exp Rheumatol 33(2 Suppl 89):S-84–S-89
11.
go back to reference Narvaez J, Bernad B, Roig-Vilaseca D, Garcia-Gomez C, Gomez-Vaquero C, Juanola X et al (2007) Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis. Semin Arthritis Rheum 37:13–19CrossRefPubMed Narvaez J, Bernad B, Roig-Vilaseca D, Garcia-Gomez C, Gomez-Vaquero C, Juanola X et al (2007) Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis. Semin Arthritis Rheum 37:13–19CrossRefPubMed
12.
go back to reference Cavazza A, Muratore F, Boiardi L, Restuccia G, Pipitone N, Pazzola G, Tagliavini E, Ragazzi M, Rossi G, Salvarani C (2014) Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations. Am J Surg Pathol 38:1360–1370CrossRefPubMed Cavazza A, Muratore F, Boiardi L, Restuccia G, Pipitone N, Pazzola G, Tagliavini E, Ragazzi M, Rossi G, Salvarani C (2014) Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations. Am J Surg Pathol 38:1360–1370CrossRefPubMed
13.
go back to reference Brack A, Martinez-Taboada V, Stanson A, Goronzy JJ, Weyand CM (1999) Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 42:311–317CrossRefPubMed Brack A, Martinez-Taboada V, Stanson A, Goronzy JJ, Weyand CM (1999) Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 42:311–317CrossRefPubMed
14.
go back to reference Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122–1128CrossRefPubMed Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122–1128CrossRefPubMed
15.
go back to reference Muratore F, Cavazza A, Boiardi L, Lo Gullo A, Pipitone N, Germano G et al (2016) Histopathologic findings of patients with biopsy-negative giant cell arteritis compared to those without arteritis: a population-based study. Arthrit Care Res 68:865–870CrossRef Muratore F, Cavazza A, Boiardi L, Lo Gullo A, Pipitone N, Germano G et al (2016) Histopathologic findings of patients with biopsy-negative giant cell arteritis compared to those without arteritis: a population-based study. Arthrit Care Res 68:865–870CrossRef
16.
go back to reference Breuer GS, Nesher R, Nesher G (2008) Negative temporal artery biopsies: eventual diagnoses and features of patients with biopsy-negative giant cell arteritis compared to patients without arteritis. Clin Exp Rheumatol 26:1103–1106PubMed Breuer GS, Nesher R, Nesher G (2008) Negative temporal artery biopsies: eventual diagnoses and features of patients with biopsy-negative giant cell arteritis compared to patients without arteritis. Clin Exp Rheumatol 26:1103–1106PubMed
17.
go back to reference Hedges TR 3rd, Gieger GL, Albert DM (1983) The clinical value of negative temporal artery biopsy specimens. Arch Ophthalmol 101:1251–1254CrossRefPubMed Hedges TR 3rd, Gieger GL, Albert DM (1983) The clinical value of negative temporal artery biopsy specimens. Arch Ophthalmol 101:1251–1254CrossRefPubMed
18.
go back to reference Roth AM, Milsow L, Keltner JL (1984) The ultimate diagnoses of patients undergoing temporal artery biopsies. Arch Ophthalmol 102:901–903CrossRefPubMed Roth AM, Milsow L, Keltner JL (1984) The ultimate diagnoses of patients undergoing temporal artery biopsies. Arch Ophthalmol 102:901–903CrossRefPubMed
19.
go back to reference Chmelewski WL, McKnight KM, Agudelo CA, Wise CM (1992) Presenting features and outcomes in patients undergoing temporal artery biopsy. A review of 98 patients. Archives Intern Med 152:1690–1695CrossRef Chmelewski WL, McKnight KM, Agudelo CA, Wise CM (1992) Presenting features and outcomes in patients undergoing temporal artery biopsy. A review of 98 patients. Archives Intern Med 152:1690–1695CrossRef
20.
go back to reference Jobard S, Magnant J, Blasco H, Ferreira-Maldent N, Griffoul I, Diot E, Maillot F (2017) Quality of life of patients treated for giant cell arteritis: a case-control study. Clin Rheumatol 36:2055–2062CrossRefPubMed Jobard S, Magnant J, Blasco H, Ferreira-Maldent N, Griffoul I, Diot E, Maillot F (2017) Quality of life of patients treated for giant cell arteritis: a case-control study. Clin Rheumatol 36:2055–2062CrossRefPubMed
21.
go back to reference Grossman C, Barshack I, Koren-Morag N, Ben-Zvi I, Bornstein G (2016) Baseline clinical predictors of an ultimate giant cell arteritis diagnosis in patients referred to temporal artery biopsy. Clin Rheumatol 35:1817–1822CrossRefPubMed Grossman C, Barshack I, Koren-Morag N, Ben-Zvi I, Bornstein G (2016) Baseline clinical predictors of an ultimate giant cell arteritis diagnosis in patients referred to temporal artery biopsy. Clin Rheumatol 35:1817–1822CrossRefPubMed
Metadata
Title
Negative temporal artery biopsy: predictive factors for giant cell arteritis diagnosis and alternate diagnoses of patients without arteritis
Authors
Gil Bornstein
Iris Barshack
Nira Koren-Morag
Ilan Ben-Zvi
Nadav Furie
Chagai Grossman
Publication date
01-10-2018
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 10/2018
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-018-4068-4

Other articles of this Issue 10/2018

Clinical Rheumatology 10/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.